Global discussions around the regulation of fluoropolymers and other perfluoroalkyl and polyfluoroalkyl substances (PFAS) are increasing, along with concerns about the impacts of these materials on the environment. This learning center brings together educational resources and expert commentary to help you follow developments in this space.
Learn & Explore: Explore the science behind PFAS, their impact on health and the environment, and the latest regulatory proposals shaping their future use in medical devices.
Commentary and Opinion: Insights from Zeus and other industry experts on emerging trends, regulations, and innovations that are shaping the future of our world.

Per- and polyfluoroalkyl substances (PFAS) are a broad group of substances that contain carbon-fluorine bonds, which are the strongest chemical bonds in organic chemistry.

On February 7, 2023, the European Chemicals Agency (ECHA) published a regulatory proposal to restrict the manufacture, placing on the market, and use of PFAS in the EU.

Stay up-to-date with the latest news from the European Chemicals Agency (ECHA) regarding per- and polyfluoroalkyl substances.

Medical devices are critical components of health care delivery, and many rely on the unique properties of PFAS. Some of these devices are necessary to save and sustain lives.

While both fluoropolymers and processing aids such as PFOA and PFOS belong to the broadest PFAS classification, their properties are very different.

Does the FDA’s recent statement on PFAS in medical devices mark the end of the debate, or is the conversation still far from over?

What if a new material could maintain PTFE’s proven performance in medical devices while expanding the possibilities even further?